Related Experiment Video
Updated: Oct 1, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
The role of KMT2 gene in human tumors
Zhi-Long Zhang1,2, Peng-Fei Yu3, Zhi-Qiang Ling4
1Zhejiang Cancer Institute (Experimental Research Center), Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, PR China.
Abstract:
Histone methylation plays a crucial role in the regulation of gene transcriptional expression, and aberration of methylation-modifying enzyme genes can lead to a variety of genetic diseases, including human cancers. The histone modified protein KMT2 (lysin methyltransferase) family are involved in cell proliferation, growth, development and differentiation through regulating gene expression, and are closely related with many blood cancers and solid tumors. In recent years, several studies have shown that mutations in the KMT2 gene occur frequently in a variety of human cancers and the mutation status of the KMT2 gene may be correlated with the occurrence, development and prognosis of some tumors. Research uncovering the clinical characteristics and molecular mechanisms of KMT2 mutation in human tumors will be helpful for early diagnosis and prognosis of tumors as well as drug development for targeted therapies.
Insights
Histone methylation, regulated by KMT2 (lysine methyltransferase) genes, is vital for gene expression. KMT2 gene mutations are linked to various cancers, impacting tumor development and prognosis.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Genetics
Background:
- Histone methylation is a key epigenetic mechanism regulating gene transcription.
- Aberrant methylation-modifying enzymes, including the KMT2 (lysine methyltransferase) family, are implicated in genetic diseases and human cancers.
- KMT2 proteins regulate essential cellular processes like proliferation, growth, development, and differentiation via gene expression control.
Purpose of the Study:
- To investigate the clinical characteristics and molecular mechanisms of KMT2 gene mutations in human tumors.
- To understand the correlation between KMT2 mutation status and tumor occurrence, development, and prognosis.
- To provide insights for early tumor diagnosis, prognosis, and targeted therapy development.
Main Methods:
- Literature review of studies on KMT2 gene mutations in various human cancers.
- Analysis of clinical data and molecular mechanisms associated with KMT2 mutations.
- Comparative analysis of mutation status across different tumor types.
Main Results:
- KMT2 gene mutations are frequently observed in diverse human cancers.
- KMT2 mutation status shows potential correlation with tumor initiation, progression, and patient outcomes.
- Specific KMT2 mutations may influence cellular functions related to cancer development.
Conclusions:
- KMT2 gene mutations are significant factors in human tumorigenesis.
- Understanding KMT2 mutation patterns can aid in predicting tumor behavior and patient prognosis.
- Further research into KMT2 mutations may facilitate the development of novel targeted cancer therapies.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mitogens and the Cell Cycle

